S'abonner

Children Newly Diagnosed with Fetal and Neonatal Alloimmune Thrombocytopenia: Neurodevelopmental Outcome at School Age - 05/07/23

Doi : 10.1016/j.jpeds.2023.02.031 
Thijs W. de Vos, MD 1, 2, 3, , Maud van Zagten, Bsc 1, Masja de Haas, MD, PhD 2, 4, 5, Dick Oepkes, MD, PhD 6, Ratna N.G.B. Tan, MD 1, C. Ellen van der Schoot, MD, PhD 3, Sylke J. Steggerda, MD, PhD 1, Linda S. de Vries, MD, PhD 1, Enrico Lopriore, MD, PhD 1, Jeanine M.M. van Klink, PhD 7
1 Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, Willem-Alexander Children's Hospital, The Netherlands 
2 Center of Clinical Transfusion Research, Sanquin Research, Amsterdam 
3 Department of Experimental Immunohematology, Sanquin Research, Amsterdam 
4 Department Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam 
5 Department of Hematology, Leiden University Medical Center, Leiden 
6 Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden 
7 Division of Child and Adolescent Psychology, Department of Pediatrics, Leiden University Medical Center, Willem-Alexander Children's Hospital, The Netherlands 

Reprint requests: Thijs W. de Vos, MD, Division of Neonatology, Room J6-182 Leiden, University Medical Center P.O. Box 9600, 2300 RC LeidenDivision of NeonatologyRoom J6-182 Leiden, University Medical Center P.O. Box 9600Leiden2300 RC

Abstract

Objective

To evaluate the neurodevelopmental outcome at school age in children newly diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT).

Study design

This observational cohort study included children diagnosed with FNAIT between 2002 and 2014. Children were invited for cognitive and neurological testing. Behavioral questionnaires and school performance results were obtained. A composite outcome of neurodevelopmental impairment (NDI) was used, defined, and subdivided into mild-to-moderate and severe NDI. Primary outcome was severe NDI, defined as IQ <70, cerebral palsy with Gross Motor Functioning Classification System level ≥ III, or severe visual/hearing impairment. Mild-to-moderate NDI was defined as IQ 70-85, minor neurological dysfunction or cerebral palsy with Gross Motor Functioning Classification System level ≤ II, or mild visual/hearing impairment.

Results

In total, 44 children were included at a median age of 12 years (range: 6-17 years). Neuroimaging at diagnosis was available in 82% (36/44) of children. High-grade intracranial hemorrhage (ICH) was detected in 14% (5/36). Severe NDI was detected in 7% (3/44); two children had high-grade ICH, and one had low-grade ICH and perinatal asphyxia. Mild-to-moderate NDI was detected in 25% (11/44); one child had high-grade ICH, and eight children were without ICH, yet for two children, neuroimaging was not performed. Adverse outcome (perinatal death or NDI) was 39% (19/49). Four children (9%) attended special needs education, three of whom had severe NDI and one had mild-to-moderate NDI. Total behavioral problems within the clinical range were reported in 12%, which is comparable with 10% in the general Dutch population.

Conclusion

Children who are newly diagnosed with FNAIT are at increased risk for long-term neurodevelopmental problems, even those without ICH.

Trial registration

The study was registered at ClinicalTrials.gov (Identifier: NCT04529382).

Le texte complet de cet article est disponible en PDF.

Keywords : intracranial hemorrhage, fetal and neonatal alloimmune thrombocytopenia, neurodevelopmental impairment, cognitive functioning, minor neurological dysfunction

Abbreviations : CP, FNAIT, GMFCS, HPA, ICH, IVH, IVIg, MND, NDI, SGA, WISC, LUMC


Plan


 The authors declare no conflicts of interest.
 Funded by Process and Product Development Diagnostic Services, Sanquin (SQI/00034).


© 2023  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 258

Article 113385- juillet 2023 Retour au numéro
Article précédent Article précédent
  • Prediction Models for Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-Analysis
  • Michelle Romijn, Paula Dhiman, Martijn J.J. Finken, Anton H. van Kaam, Trixie A. Katz, Joost Rotteveel, Ewoud Schuit, Gary S. Collins, Wes Onland, Heloise Torchin
| Article suivant Article suivant
  • The Effect of Smartphone Video on Lead Time to Diagnosis of Infantile Spasms
  • Chethan K. Rao, Douglas R. Nordli, Joshua J. Cousin, Danielle S. Takacs, Raj D. Sheth

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.